Article Details

Zenas BioPharma Independent Director Acquires 447% More Stock

Retrieved on: 2025-10-12 19:30:50

Tags for this article:

Click the tags to see associated articles and topics

Zenas BioPharma Independent Director Acquires 447% More Stock. View article details on hiswai:

Excerpt

Zenas BioPharma, Inc. (NASDAQ:ZBIO) shareholders (or potential shareholders) will be happy to see that the Independent Director, Hongbo Lu, ...

Article found on: news.futunn.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo